Emerging evidence indicates that exosomes derived from CML cells carry BCR-ABL mRNA and proteins, and can transfer drug resistance to sensitive cells (Zheng, Wang & Ge, 2025). Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.